Korkormicins, novel depsipeptide antitumor antibiotics fromMicromonospora sp C39500: Fermentation, precursor directed biosynthesis and biological activities
Citations Over Time
Abstract
Micromonospora sp C39500, isolated in our laboratory from a soil sample, produced a complex of seven novel depsipeptide antitumor antibiotics, designated korkormicins. The major component of the complex, korkormicin A, has a MW of 1452 and a molecular formula of C66H84N16O22. Korkormicin A exhibits potent in vivo antitumor activity against P388 leukemia and M109 lung carcinoma implanted intraperitoneally (ip) in mice, with effective doses of 0.05-0.20 mg kg-1 injection-1, for five or three ip injections, respectively. It is also active against Gram-positive bacteria but inactive against Gram-negative bacteria. The production of korkormicin A was enhanced by 3-fold when 0.1% L-valine was added to the production culture at 48 h. A titer of 401.0 micrograms ml-1 was achieved in the fermenter culture supplemented with 0.1% L-valine.
Related Papers
- → Mirabamides E−H, HIV-Inhibitory Depsipeptides from the Sponge Stelletta clavosa(2011)82 cited
- → Biosynthesis of depsipeptides, or Depsi: The peptides with varied generations(2020)54 cited
- → Recent Developments in Depsipeptide Research(2002)96 cited
- → Cyclic depsipeptides as potential cancer therapeutics(2014)66 cited
- → The Bicyclic Depsipeptide Family of Histone Deacetylase Inhibitors(2007)10 cited